Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
Phase 2
Terminated
- Conditions
- Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema
- Interventions
- Drug: THR-687 dose level 1Drug: THR-687 dose level 2Drug: THR-687 selected dose level
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Oxurion
- Target Recruit Count
- 16
- Registration Number
- NCT05063734
- Locations
- 🇺🇸
Salehi Retina Institute Inc., Huntington Beach, California, United States
🇺🇸California Eye Specialists Medical Group, Inc., Pasadena, California, United States
🇺🇸Retinal Consultants Medical Group, Sacramento, California, United States
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Phase 2
Completed
- Conditions
- Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema
- Interventions
- Drug: THR-149 dose level 1Drug: THR-149 dose level 2Drug: THR-149 dose level 3Drug: THR-149 0.13mgDrug: THR-149 0.13mg + aflibercept 2mg
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Oxurion
- Target Recruit Count
- 135
- Registration Number
- NCT04527107
- Locations
- 🇺🇸
Retinal Research Institute, LLC, Phoenix, Arizona, United States
🇺🇸Retina Associates, Tucson, Arizona, United States
🇺🇸Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)
Phase 2
Completed
- Conditions
- Diabetic RetinopathyMacular EdemaDiabetes Mellitus
- Interventions
- First Posted Date
- 2018-04-17
- Last Posted Date
- 2019-08-02
- Lead Sponsor
- Oxurion
- Target Recruit Count
- 70
- Registration Number
- NCT03499223
- Locations
- 🇧🇪
CHU Brugmann, Brussels, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
🇫🇷Centre Rétine Gallien, Bordeaux, France
News
No news found